Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells

Citation
E. Flescher et al., Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells, ANTICANC R, 20(6B), 2000, pp. 4441-4444
Citations number
17
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
20
Issue
6B
Year of publication
2000
Pages
4441 - 4444
Database
ISI
SICI code
0250-7005(200011/12)20:6B<4441:AEMRG1>2.0.ZU;2-L
Abstract
Background: We recently found that aspirin induces the expression of P-glyc oprotein (P-gp), a protein mediating drug resistance, in human prostate can cer cells. The purpose of this study was to evaluate the effect of aspirin on the expression of P-gp in a different human cancer type, i.e., T lymphom a. Furthermore, we analyzed this effect at the level of the gene encoding P -gp, MDR1, and of the transcription factor (NF-IL6), regulating this gene. Materials and Methods: NF-IL6 was assayed by the electrophoretic mobility s hift assay, MDR1 mRNA was assayed by the reverse transcriptase polymerase c hain reaction (RT-PCR), and P-gp was assayed by Western blotting. Results: aspirin, at plasma attainable levels, induced NF-IL6 DNA-binding activity, and increased MDR1 mRNA expression (by up to 140%), as well as the expressi on of P-gp, in Molt-4 cells. Conclusions: This study suggests that treatmen t with aspirin induces a cellular signal culminating in the enhancement of P-gp expression in T lymphoma Molt-4 cells.